A total of 37 institutions have reported a stake in TScan Therapeutics, Inc. (NASDAQ:TCRX) as of December 2025, according to recent 13F filings with the SEC.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 31 Dec, 2025 | 2,475,733 | 157,817 | 6.81% | $2,475,733.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 1,848,695 | -534,069 | -22.41% | $1,848,695.00 |
| Aberdeen Group plc | 31 Dec, 2025 | 1,785,241 | 430,421 | 31.77% | $1,785,241.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 1,141,069 | 311,150 | 37.49% | $1,141,069.00 |
| DC Funds, LP | 31 Dec, 2025 | 630,000 | 0 | 0.00% | $630,000.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 562,153 | -5,504 | -0.97% | $562,360.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 388,284 | 306,968 | 377.50% | $388,284.00 |
| MARSHALL WACE, LLP | 31 Dec, 2025 | 339,240 | 292,610 | 627.51% | $339,240.00 |
| GSA CAPITAL PARTNERS LLP | 31 Dec, 2025 | 226,164 | 226,164 | 0.00% | $226.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 225,829 | -621,708 | -73.35% | $225,829.00 |
| STATE STREET CORP | 31 Dec, 2025 | 207,313 | 10,000 | 5.07% | $207,313.00 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 31 Dec, 2025 | 188,152 | 188,152 | 0.00% | $188,152.00 |
| BROWN BROTHERS HARRIMAN & CO | 31 Dec, 2025 | 143,051 | 0 | 0.00% | $143,051.00 |
| LETKO, BROSSEAU & ASSOCIATES INC | 31 Dec, 2025 | 95,875 | 0 | 0.00% | $95,875.00 |
| NewEdge Wealth, LLC | 31 Dec, 2025 | 91,463 | 0 | 0.00% | $91,463.00 |
| GOLDMAN SACHS GROUP INC | 31 Dec, 2025 | 86,903 | -44,077 | -33.65% | $86,903.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Dec, 2025 | 74,467 | -12,849 | -14.72% | $74,541.00 |
| STIFEL FINANCIAL CORP | 31 Dec, 2025 | 72,400 | -25,000 | -25.67% | $72,400.00 |
| UBS Group AG | 31 Dec, 2025 | 55,198 | 44,125 | 398.49% | $55,198.00 |
| DC Investments Management, LLC | 31 Dec, 2025 | 35,563 | 0 | 0.00% | $35,563.00 |